Skip to content

Azenta AZTA Additional Paid-In Capital

Additional Paid-In Capital at other companies

Danaher logo
DanaherDHR
$17.3B+2.7%
Labcorp Holdings logo
Labcorp HoldingsLH
$0-100%
Illumina logo
IlluminaILMN
$7.86B+3.3%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$1.15B+0.5%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$1.85B+5.5%
BioLife Solutions logo
BioLife SolutionsBLFS
$710.81M+3.3%

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-16.3%
Enterprise value$1.03B
P/S1.8×-0.2×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's additional paid-in capital?
Azenta (AZTA) reported additional paid-in capital of $538.78M in Q1 2026.
What is the long-term trend for Azenta's additional paid-in capital?
Over 4 years (2020 to 2025), Azenta's additional paid-in capital has grown at a -27.7% compound annual growth rate (CAGR), from $1.94B to $529.61M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.